Cargando…

Cystatin C Is Downregulated in Prostate Cancer and Modulates Invasion of Prostate Cancer Cells via MAPK/Erk and Androgen Receptor Pathways

Cystatin C is believed to prevent tumor progression by inhibiting the activities of a family of lysosomal cysteine proteases. However, little is known about the precise mechanism of cystatin C function in prostate cancer. In the present study, we examined the expression of cystatin C and its associa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wegiel, Barbara, Jiborn, Thomas, Abrahamson, Magnus, Helczynski, Leszek, Otterbein, Leo, Persson, Jenny Liao, Bjartell, Anders
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2776515/ https://www.ncbi.nlm.nih.gov/pubmed/19956729 http://dx.doi.org/10.1371/journal.pone.0007953

Ejemplares similares

Multiple Cellular Mechanisms Related to Cyclin A1 in Prostate Cancer Invasion and Metastasis
por: Wegiel, Barbara, et al.
Publicado: (2008)

Heme oxygenase-1 in macrophages controls prostate cancer progression
por: Nemeth, Zsuzsanna, et al.
Publicado: (2015)

REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer
por: Svensson, Charlotte, et al.
Publicado: (2014)

Automatic registration of multi-modal microscopy images for integrative analysis of prostate tissue sections
por: Lippolis, Giuseppe, et al.
Publicado: (2013)

Emphasizing the role of Wnt5a protein expression to predict favorable outcome after radical prostatectomy in patients with low-grade prostate cancer
por: Khaja, Azharuddin Sajid Syed, et al.
Publicado: (2012)

Elevated Level of Wnt5a Protein in Localized Prostate Cancer Tissue Is Associated with Better Outcome
por: Syed Khaja, Azharuddin Sajid, et al.
Publicado: (2011)

Cartilage oligomeric matrix protein promotes prostate cancer progression by enhancing invasion and disrupting intracellular calcium homeostasis
por: Englund, Emelie, et al.
Publicado: (2017)

Prolonged androgen deprivation leads to downregulation of androgen receptor and prostate-specific membrane antigen in prostate cancer cells
por: LIU, TIANCHENG, et al.
Publicado: (2012)

TRIM36, a novel androgen-responsive gene, enhances anti-androgen efficacy against prostate cancer by inhibiting MAPK/ERK signaling pathways
por: Liang, Chao, et al.
Publicado: (2018)

Cystatin C uptake in the eye
por: Wassélius, Johan, et al.
Publicado: (2004)

Lower prostate cancer risk in Swedish men with the androgen receptor E213 A-allele
por: Bentmar Holgersson, Magdalena, et al.
Publicado: (2017)

Downregulation of PARVA promotes metastasis by modulating integrin-linked kinase activity and regulating MAPK/ERK and MLC2 signaling in prostate cancer
por: Huang, Cong, et al.
Publicado: (2021)

Androgen resistance in prostate cancer
por: Waxman, J, et al.
Publicado: (2008)

Go Green: The Anti-Inflammatory Effects of Biliverdin Reductase
por: Wegiel, Barbara, et al.
Publicado: (2012)

miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients
por: Hagman, Z, et al.
Publicado: (2013)

Androgen receptor-mediated downregulation of microRNA-221 and -222 in castration-resistant prostate cancer
por: Gui, Bin, et al.
Publicado: (2017)

The STAT3 inhibitor GPB730 enhances the sensitivity to enzalutamide in prostate cancer cells
por: Hellsten, Rebecka, et al.
Publicado: (2022)

Androgen deprivation and cognition in prostate cancer
por: Salminen, E, et al.
Publicado: (2003)

Mechanisms of Androgen-Independent Prostate Cancer
por: Saraon, Punit, et al.
Publicado: (2014)

Plasma Androgen Receptor in Prostate Cancer
por: Conteduca, Vincenza, et al.
Publicado: (2019)

S-Adenosylmethionine affects ERK1/2 and STAT3 pathway in androgen-independent prostate cancer cells
por: Schmidt, Thomas
Publicado: (2022)

Biological and Clinical Significance of Androgens and Androgen Receptor in Prostate Cancer
por: Koochekpour, Shahriar
Publicado: (2014)

Secreted cystatins decrease proliferation and enhance apoptosis of human leukemic cells
por: Hunaiti, Samar, et al.
Publicado: (2020)

Androgen downregulation of miR-760 promotes prostate cancer cell growth by regulating IL6
por: Wang, Shuo, et al.
Publicado: (2020)

Exploring anti-androgen therapies in hormone dependent prostate cancer and new therapeutic routes for castration resistant prostate cancer
por: Harris, Anna E., et al.
Publicado: (2022)

βKlotho inhibits androgen/androgen receptor-associated epithelial-mesenchymal transition in prostate cancer through inactivation of ERK1/2 signaling
por: Liu, Zhao, et al.
Publicado: (2018)

Androgen-regulation of the protein tyrosine phosphatase PTPRR activates ERK1/2 signalling in prostate cancer cells
por: Munkley, Jennifer, et al.
Publicado: (2015)

Externally added cystatin C reduces growth of A375 melanoma cells by increasing cell cycle time
por: Wallin, Hanna, et al.
Publicado: (2021)

Estradiol suppresses tissue androgens and prostate cancer growth in castration resistant prostate cancer
por: Montgomery, Bruce, et al.
Publicado: (2010)

Stabilization, Characterization, and Selective Removal of Cystatin C Amyloid Oligomers
por: Östner, Gustav, et al.
Publicado: (2013)

Prostate cancer, insulin, and androgen deprivation therapy
por: Stattin, P, et al.
Publicado: (2003)

Arsenic and Prostate Cancer: Acquiring Androgen Independence
por: Tibbetts, John
Publicado: (2005)

Maximal androgen blockade for advanced prostate cancer
por: Mukha, Rajiv Paul, et al.
Publicado: (2010)

Posttranslational Modification of the Androgen Receptor in Prostate Cancer
por: van der Steen, Travis, et al.
Publicado: (2013)

Autophagy in Prostate Cancer and Androgen Suppression Therapy
por: Ziparo, Elio, et al.
Publicado: (2013)

Anti-androgenic effects of flavonols in prostate cancer
por: Boam, Tristan
Publicado: (2015)

Splice Variants of Androgen Receptor and Prostate Cancer
por: Caffo, Orazio, et al.
Publicado: (2016)

Regulation of androgen receptor variants in prostate cancer
por: Zhu, Yezi, et al.
Publicado: (2020)

Androgen receptor co-regulation in prostate cancer
por: Senapati, Dhirodatta, et al.
Publicado: (2020)

Androgen Receptor-Mediated Transcription in Prostate Cancer
por: Özturan, Doğancan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1u7oc2tsfuqet4dt0e5563i2ud